Panagora Asset Management Inc Cocrystal Pharma, Inc. Transaction History

Panagora Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$0.7 - $1.58 $728 - $1,643	-1,040 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$0.39 - $2.05 $140 - $735	359 Added 52.72%	1,040 $1,000
Q3 2019 Nov 12, 2019	SELL	$1.69 - $2.88 $7,726 - $13,167	-4,572 Reduced 87.04%	681 $1,000
Q2 2019 Aug 09, 2019	SELL	$2.06 - $2.75 $9,282 - $12,391	-4,506 Reduced 46.17%	5,253 $12,000
Q1 2019 May 15, 2019	SELL	$2.65 - $4.14 $12,592 - $19,673	-4,752 Reduced 32.75%	9,759 $27,000
Q4 2018 Feb 14, 2019	BUY	$1.6 - $3.68 $6,998 - $16,096	4,374 Added 43.15%	14,511 $52,000
Q3 2018 Nov 13, 2018	BUY	$2.3 - $4.95 $15,175 - $32,660	6,598 Added 186.44%	10,137 $25,000
Q2 2018 Aug 14, 2018	BUY	$1.79 - $6.25 $6,334 - $22,118	3,539 New	3,539 $13,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $17.6M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.